Artificial Cells, Cell Engineering and Therapy

THE ARTIFICIAL CELL
Introduction to artificial cells: concept, history, design, current status and future
S Prakash, J R Bhathena and H Chen, McGill University, Canada
Polymeric hydrophilic polymers in targeted drug delivery
K Poon, V Castellino and Y-L Cheng, University of Toronto, Canada
The artificial cell design: liposomes
G Barratt, Centre d'Etudes Pharmaceutiques, France
The artificial cell design: nanoparticles
W Yu and S Su, Celsion Corporation, USA
CELL ENGINEERING
The cutting edge: apoptosis and therapeutic opportunity
C Griffin, D Gueorguieva, A McLachlan-Burgess, M Somayajulu-Nitu and S Pandey, University of Windsor, Canada
Bone marrow stromal cells in myocardial regeneration and the role of cell signalling
R Atoui, R C J Chiu and D Shm-Tim, McGill University, Canada
Musculoskeletal tissue engineering with skeletal muscle-derived stem cells
K A Corsi and J Huard, University of Pittsburgh, USA
ARTIFICIAL CELLS FOR CELL THERAPY
Artificial cell for oral delivery of live bacterial cells for therapy
S Prakash, J Bhathena and A M Uurbanska, McGill University, Canada
Artificial cells in liver disease
V Dixit, University of California, USA
Artificial cells as a novel approach to gene therapy
M Potter, A Li, P Cirone, F Shen and P Chang, McMaster University, Canada
Capillary devices for therapy
J W Kawiak, L H Granicka, A Werynski and J M Wojcicki, Institute of Biocybernetics and Biomedical Engineering PAS and Medical Centre of Postgraduate Education, Poland
THE CLINICAL RELEVANCE OF ARTIFICIAL CELLS AND CELL ENGINEERING
Artificial cells in medicine: with emphasis on blood substitutes
T M W Chang, McGill University, Canada
Bone marrow stromal cells as 'universal donor cells' for myocardial regeneration therapy
J Luo, R C-J Chiu and D Shum-Tim, McGill University, Canada
Myocardial regeneration, tissue engineering and therapy
R L kao, C E Ganote, D G Pennington and I W Browder, East Tennessee State University, USA
Kidney diseases and potentials of artificial cells
S Prakash, T Lim and W Ouyang, McGill University, Canada
Engineered cells for treatment of diabetes
S Efrat, Tel Aviv University, Israel
Drug delivery system for active brain targeting
X-G Mei, Beijing Institute of Pharmacology and Toxicology, China
Artificial cells in enzyme therapy with emphasis on tyrosinase for melanoma in mice
B Yu and T M S Chang, McGill University, Canada
Stem cell and regenerative medicine: commercial and pharmaceutical implications
L E Cruz and S P Azevedo, Cryopraxis Criobiologia Ltd, Brazil
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present therapy and therapeutic potential of cell-based therapy
S-P Luh and S-Y Jiang, Tzu-Chi Medical University Hospital and R-Y Shyu, National Defence Medical Centre, Taiwan
Inflammatory bowel diseases: current treatment strategies and potential for drug delivery using artificial cell microcapsules
D Amre, University of Montreal, Canada and P D Amre and S Prakash, McGill University, Canada
Carrier-mediated and artificial-cell targeted cancer drug delivery
W C Zamboni, University of Pittsburgh, USA